| OHSU # 3015 |
Covalent inhibitors of PARP-16 for cancer treatment |
Michael (Mike) Cohen, Daniel Bejan, Sunil Sundalam |
| OHSU # 2944 |
Small molecules promoting nerve regeneration |
Michael (Mike) Cohen, Beth Habecker, Haihong Jin, Ryan Gardner, Matthew Blake |
| OHSU # 2757 |
Clickable, photoactivatable NAD+ analogues as probes for PARP and other NAD+-binding targets |
Sunil Sundalam, Michael (Mike) Cohen |
| OHSU # 2750 |
Compositions for treatment of neurological and oxidative stress disorders |
Michael (Mike) Cohen, Michael Forte, Justina Sileikyte, Jordan Devereaux, Aaron Nilsen, Paolo Bernardi |
| OHSU # 2431 |
Selective PARP11 inhibitor for the treatment of cancer |
Michael (Mike) Cohen, Ilsa Kirby |
| OHSU # 2162 |
A chemical genetic approach for identifying family-member specific targets of monoPARPs |
Michael (Mike) Cohen, Ian Carter-O'Connell, Rory Morgan, Haihong Jin |
| OHSU # 1988 |
Novel biosensor for direct measurement of bioavailable NAD+ |
Richard (Dick) Goodman, Michael (Mike) Cohen, Xiaolu (Lulu) Cambronne, Melissa Stewart |